Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015)-Reference-Cited by-同舟云学术

Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015)

Published:2017-05-05 Issue:7 Volume:27 Page:753-761
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Kharkar Prashant S.¹

Affiliation:

1. Department of Pharmaceutical Chemistry, SPP School of Pharmacy and Technology Management, SVKM’s NMIMS, Mumbai, India

Funder

Department of Biotechnology, Ministry of Science and Technology

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2017.1325465

Reference49 articles.

1. Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution

2. What are the limitations of targeted cancer therapies? Bethesda, MD: National Cancer Institute (NCI), National Institutes of Health (NIH), 2014. Available at: https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet#q6.

3. Dynamics between Cancer Cell Subpopulations Reveals a Model Coordinating with Both Hierarchical and Stochastic Concepts

4. Understanding and targeting cancer stem cells: therapeutic implications and challenges

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein sumoylation in normal and cancer stem cells;Frontiers in Molecular Biosciences;2022-12-19

2. Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers;Cell Biology and Toxicology;2022-09-23

3. Colorectal Cancer;Handbook of Research on Natural Products and Their Bioactive Compounds as Cancer Therapeutics;2022-03-18

4. Targeting Cancer Stem Cells with Repurposed Drugs to Improve Current Therapies;Recent Patents on Anti-Cancer Drug Discovery;2021-05

5. EpCAM expression in esophageal cancer and its correlation with immunotherapy of solitomab;Journal of Thoracic Disease;2021-04